EMAIL THIS PAGE TO A FRIEND

Advanced healthcare materials

Molecularly engineered self-assembling membranes for cell-mediated degradation.


PMID 25413155

Abstract

The use of peptide engineering to develop self-assembling membranes that are responsive to cellular enzyme activities is reported. The membranes are obtained by combining hyaluronan (HA) and a rationally designed peptide amphiphile (PA) containing a proteolytic domain (GPQGIWGQ octapeptide) sensitive to matrix metalloproteinase-1 (MMP-1). Insertion of an octapeptide in a typical PA structure does not disturb its self-assembly into fibrillar nanostructures neither the ability to form membranes with HA. In vitro enzymatic degradation with hyaluronidase and MMP-1 shows that membranes containing the MMP-1 substrate exhibit enhanced enzymatic degradation, compared with control membranes (absence of MMP-1 cleavable peptide or containing a MMP-1 insensitive sequence), being completely degraded after 7 days. Cell viability and proliferation is minimally affected by the enzymatically cleavable functionality of the membrane, but the presence of MMP-1 cleavable sequence does stimulate the secretion of MMP-1 by fibroblasts and interfere with matrix deposition, particularly the deposition of collagen. By showing cell-responsiveness to biochemical signals presented on self-assembling membranes, this study highlights the ability of modulating certain cellular activities through matrix engineering. This concept can be further explored to understand the cellular remodeling process and as a strategy to develop artificial matrices with more biomimetic degradation for tissue engineering applications.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

12804
HBTU, ≥98.0% (T)
C11H16F6N5OP
387649
N,N-Diisopropylethylamine, purified by redistillation, 99.5%
C8H19N
496219
N,N-Diisopropylethylamine, 99.5%, biotech. grade
C8H19N
D125806
N,N-Diisopropylethylamine, ReagentPlus®, ≥99%
C8H19N
03440
N-Ethyldiisopropylamine, BASF quality, ≥98.0%
C8H19N
03439
N-Ethyldiisopropylamine solution, for peptide synthesis, ~2 M in 1-methyl-2-pyrrolidinone
C8H19N
P5585
Palmitic acid, BioXtra, ≥99%
C16H32O2
P0500
Palmitic acid, ≥99%
C16H32O2
P0625
Palmitic acid, Grade II, ~95%
C16H32O2
43051
Palmitic acid, certified reference material, TraceCERT®
C16H32O2
1492007
Palmitic acid, United States Pharmacopeia (USP) Reference Standard
C16H32O2
76119
Palmitic acid, analytical standard
C16H32O2
27734
Palmitic acid, ≥98% palmitic acid basis (GC)
C16H32O2
76122
Palmitic acid, purum, ≥98.0% (GC)
C16H32O2
W283207
Palmitic acid, ≥95%, FCC, FG
C16H32O2
PHR1120
Palmitic acid, Pharmaceutical Secondary Standard; Certified Reference Material
C16H32O2
P0090000
Palmitic acid, European Pharmacopoeia (EP) Reference Standard
C16H32O2
W283215
Palmitic acid, natural, 98%, FG
C16H32O2
411027
Piperidine, ≥99.5%, purified by redistillation
C5H11N
571261
Piperidine, biotech. grade, ≥99.5%
C5H11N
104094
Piperidine, ReagentPlus®, 99%
C5H11N
76046
Piperidine, analytical standard
C5H11N
80642
Piperidine, purum, ≥96.0% (GC/T)
C5H11N
W290807
Piperidine, ≥99%, FCC
C5H11N
80645
Piperidine solution, for peptide synthesis, 20% in DMF
C5H11N
233781
Triisopropylsilane, 98%
C9H22Si